17-40657404-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152349.3(KRT222):āc.607A>Gā(p.Ile203Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000472 in 1,611,222 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152349.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRT222 | NM_152349.3 | c.607A>G | p.Ile203Val | missense_variant | 5/6 | ENST00000394052.5 | NP_689562.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRT222 | ENST00000394052.5 | c.607A>G | p.Ile203Val | missense_variant | 5/6 | 1 | NM_152349.3 | ENSP00000377616.3 | ||
ENSG00000264058 | ENST00000476049.1 | n.607A>G | non_coding_transcript_exon_variant | 5/13 | 5 | ENSP00000463483.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000999 AC: 25AN: 250204Hom.: 0 AF XY: 0.000126 AC XY: 17AN XY: 135348
GnomAD4 exome AF: 0.0000466 AC: 68AN: 1459054Hom.: 0 Cov.: 30 AF XY: 0.0000606 AC XY: 44AN XY: 725836
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 17, 2024 | The c.607A>G (p.I203V) alteration is located in exon 5 (coding exon 5) of the KRT222 gene. This alteration results from a A to G substitution at nucleotide position 607, causing the isoleucine (I) at amino acid position 203 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at